Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaspian Sunrise Regulatory News (CASP)

Share Price Information for Caspian Sunrise (CASP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.35
Bid: 3.30
Ask: 3.40
Change: 0.00 (0.00%)
Spread: 0.10 (3.03%)
Open: 3.35
High: 3.35
Low: 3.35
Prev. Close: 3.35
CASP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational update and total voting rights

31 Mar 2010 11:11

RNS Number : 5070J
Roxi Petroleum Plc
31 March 2010
 



For immediate release

31 March 2010

 

Roxi Petroleum ("Roxi" or "the Company")

Operational update and total voting rights

 

Roxi Petroleum (Roxi Petroleum ("Roxi" or "the Company"), the Central Asian oil and gas company with a focus on Kazakhstan, is pleased to announce the following corporate update:

 

·; Canamens exercise stage 2 of the BNG Asset agreement

·; Roxi repays the US$3 million Arawak convertible loan

·; Arawak exercise 2 million warrants

 

BNG

 

Roxi is pleased to announce that Canamens Energy BV ("Canamens") has informed Roxi that it has exercised its option under stage 2 of the BNG disposal agreement, approved by Roxi shareholders in November 2009, to purchase a further 12 per cent of the BNG asset from Roxi for a further funding commitment of US$23 million, all of which will be treated as a loan to BNG Energy B.V., repayable from future revenue from production at the BNG Contract area.

 

In December 2009, under stage 1 of the BNG disposal agreement, Canamens acquired 23% of the BNG asset to Roxi in return for funding commitments of US$32 million from Canamens, of which US$27 million has been treated as a loan to BNG Energy B.V repayable from future production at the BNG Contract Area. Canamens also paid Roxi US$2 million on signing.

 

Following the exercise of option by Canamens, Roxi will hold a 23.41 per cent. interest in the BNG Contract area.

 

As a result of Canamens decision to exercise their option under stage 2, Roxi's 2010 BNG work programme commitments are now fully funded.

 

Repayment of Arawak convertible loan

 

The Directors also announce that Kuat Oraziman, a director of the Company, has made available a loan of US$3 million to allow the repayment of a US$3 million convertible loan due to Arawak Energy plc ("Arawak"). Had the Arawak loan not been repaid before 31 March 2010, Arawak had the option to convert the amount due with interest to 20,174,457 Roxi shares representing 4.84 per cent of Roxi's issued share capital.

 

Mr Oraziman's loan is to Galaz and Company LLP and has been made under the financial assistance provisions of Kazakh company law. The loan is interest free and due for repayment on 1 July 2010.

 

 

As Mr Oraziman is a director of the Company the loan is a related party transaction. It is the view of all the Independent Directors, being all the directors except Mr. Oraziman, who have been so advised by Matrix Corporate Capital LLP, that the loan from Mr Oraziman is in the best interests of the Company. In providing advice to the Independent Directors Matrix Corporate capital LLP has taken into account the Independent Directors' commercial assessment.

 

Exercise of warrants

 

Roxi was notified on 29 March 2010 that Arawak has exercised 2 million warrants at a price of 10 p per share, for an aggregate consideration of £200,000. Consequently, Arawak's shareholding in Roxi has increased from 21,168,721, representing 5.07 per cent. to 23,168,721 shares representing 5.53 per cent of Roxi's issued share capital.

 

Update on LG / Galaz

 

The proposed transaction with LGI in respect of Roxi's interest in the Galaz assets is progressing well and a further announcement will be made in due course.

 

Total Voting Rights

 

In line with the Financial Services Authority's Disclosure and Transparency Rules, as at 31 March 2010, including the matters referred to in this announcement, the Company's total issued share capital is 419,218,386 ordinary shares of 1p each.

 

Roxi does not hold any shares in treasury.

 

Therefore, the total number of voting rights in Roxi is 419,218,386, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in Roxi under the FSA's Disclosure and Transparency Rules.

 

 

David Wilkes CEO commented

 

"Canamens decision to exercise stage 2 of the BNG assets disposal agreement is a very positive development. As a result Roxi's 2010 BNG work programme commitments are now fully covered.

 

 

 

Enquiries

Roxi Petroleum plc

David Wilkes CEO

 

+7 727 244 0920

 

 

Buchanan Communications (Financial PR)

Tim Thompson / Ben Romney

 

+44 207 466 5000

Matrix Corporate Capital LLP (NOMAD and broker)

Alastair Stratton / Anu Tayal

 

+44 203 206 7000

 

 

 

About Roxi

Roxi Petroleum was admitted to the London Stock Exchange AIM on 22 May 2007 with intent to acquire controlling interests in and develop oil and gas assets in Central Asia. Roxi's strategy is to target oil discoveries and mature exploration acreage which have reserves and production upside. This strategy has allowed the Company to rapidly acquire a number of excellent exploration and development assets in Western and Central Kazakhstan, covering a combined area of 1,880 km2. These assets have, upon acquisition, significant reserves under the Kazakh Government's reserve classifications of C1+C2+C3. It is Roxi's strategy to use available modern technology to move the reserves from the current classifications to internationally recognized SPE classifications recognized by the AIM and other financial markets. Roxi will also add further value to the assets by bringing these reserves into production.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCJBMMTMBBJBMM
Date   Source Headline
25th Apr 20241:08 pmRNSGeneral Meeting Results
24th Apr 20247:00 amRNSIssue of Equity and Option Awards
8th Apr 20247:00 amRNSProposed Acquisition, Rule 9 Waiver and GM Notice
25th Mar 20247:00 amRNSStrategic & Operational Update
16th Feb 20247:00 amRNSBNG Operational update
21st Dec 20237:00 amRNSOperational Update
31st Oct 20237:00 amRNSOperational update
25th Sep 20237:00 amRNSInterim results for six months ended 30 June 2023
31st Jul 202312:49 pmRNSGM results
31st Jul 20237:00 amRNSGeneral Meeting & BNG and Caspian Explorer updates
11th Jul 202312:50 pmRNSHolding(s) in Company
10th Jul 20237:00 amRNSBoard change, Posting of the 2022 Results
7th Jul 20237:30 amRNSRestoration- Caspian Sunrise plc
7th Jul 20237:00 amRNSAnnual Report for the Year Ended 31 December 2022
3rd Jul 20237:30 amRNSSuspension - Caspian Sunrise plc
30th Jun 20233:51 pmRNSAGM results
30th Jun 20237:00 amRNSAGM Statement
12th Jun 20237:00 amRNS50% Sale of Caspian Explorer & Operational Update
1st Jun 20239:26 amRNSAGM and 2022 Accounts update
7th Mar 20237:00 amRNSCaspian Explorer contract signed & Dividend update
20th Feb 20237:00 amRNSCaspian Explorer update & Dividend update
30th Jan 20237:00 amRNSDeep well update
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
16th Jan 20232:05 pmRNSSecond Price Monitoring Extn
16th Jan 20232:00 pmRNSPrice Monitoring Extension
16th Jan 202311:05 amRNSSecond Price Monitoring Extn
16th Jan 202311:00 amRNSPrice Monitoring Extension
16th Jan 20237:00 amRNSTender Update
12th Jan 20237:00 amRNSThird Monthly Dividend Declaration
22nd Dec 20228:14 amRNSOperational Update
5th Dec 20227:00 amRNSSecond Monthly Dividend Declaration
11th Nov 20227:00 amRNSDividend Details
7th Nov 202211:05 amRNSSecond Price Monitoring Extn
7th Nov 202211:00 amRNSPrice Monitoring Extension
4th Nov 20224:40 pmRNSSecond Price Monitoring Extn
4th Nov 20224:35 pmRNSPrice Monitoring Extension
4th Nov 20227:00 amRNSOperational Update and Dividend Declaration
3rd Oct 20224:41 pmRNSSecond Price Monitoring Extn
3rd Oct 20224:36 pmRNSPrice Monitoring Extension
26th Sep 202210:14 amRNSReplacement Announcement for Interim Results
26th Sep 20227:00 amRNSInterim results for six months ended 30 June 2022
11th Aug 20227:00 amRNSResult of GM
30th Jun 20222:21 pmRNSResult of AGM
30th Jun 20228:53 amRNSOraziman family holdings
27th Jun 20227:00 amRNSAnnual Report and Financial Statements
22nd Jun 20228:32 amRNSUK High Court confirms Capital Reduction
6th Jun 20227:00 amRNSOperational and impact of Russian sanctions update
31st May 20227:00 amRNSNotice of AGM
30th May 20227:00 amRNSUK Oil Company Windfall Tax & Dividend Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.